Longevity Venture Partners

An early-stage venture capital fund investing in Silvertech, Healthcare, and Wellness sectors.

Venture Capital Active Baltimore, United States Est. 2020
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
A Round, Pre-Seed, Seed

About

Longevity Venture Partners (LVP) is an early-stage venture capital firm that invests in companies developing technologies and solutions to support the aging population. The firm focuses on Silvertech, Healthcare, and Wellness sectors, aiming to improve independence and well-being for older adults. LVP leverages a commercial ecosystem and an international network to accelerate the development and market entry of innovative solutions. The fund invests in Israeli companies, providing capital, industry expertise, and access to a network of experts and a pilot ecosystem within the CommuniCare Family of Companies.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences8
Education & Knowledge Technologies1
Media & Entertainment Technologies1
Agriculture & Food Technologies1

Q&A

What is Longevity Venture Partners' primary investment focus?
Longevity Venture Partners is an early-stage venture capital fund that focuses on nurturing entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
When was Longevity Venture Partners founded?
Longevity Venture Partners was founded in 2020.
Who are the co-founders of Longevity Venture Partners?
The co-founders of Longevity Venture Partners are Jonathan Ringo, who serves as Co-founder & General Partner, and Raissa Hacohen, who is Co-founder & Managing Partner.
What investment stages does Longevity Venture Partners typically target?
Longevity Venture Partners primarily targets Pre-Seed, Seed, and A Round investment stages.
Can you name a notable recent investment by Longevity Venture Partners?
In May 2024, Longevity Venture Partners invested in Urologic Health, which raised an $11M Seed round. They also invested in Lembas, which raised a $3.6M Pre-Seed round in January 2024.
Which sector has Longevity Venture Partners invested in the most?
Longevity Venture Partners has a strong concentration in the Health Tech & Life Sciences sector, with 8 of their portfolio companies in this area.
Has Longevity Venture Partners had any exits?
Yes, Longevity Venture Partners had an exit in November 2022 with the acquisition of OutSense Diagnostics, a company focused on toilet-based IoT sensors for detecting GI conditions.
What is the investment range for Longevity Venture Partners?
Longevity Venture Partners' investment range is between $500K and $12.7M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)